FDA: Page 95


  • Beckman initiates Class I recall of flow cytometers

    FDA is concerned inaccurate results provided by the devices could lead to serious injuries or deaths.

    By Nov. 22, 2018
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA device inspections hit high amid overseas oversight push

    The agency conducted 2,952 inspections of medical device manufacturers last year, an increase of 46% over 2007.

    By Nov. 22, 2018
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • Image attribution tooltip
    ECRI Institute
    Image attribution tooltip

    ECRI launches clinical guidelines site to replace resource HHS shuttered

    The new portal will include "expertly vetted, evidence-based guideline briefs and scorecards" for the healthcare community, according to the Pennsylvania-based nonprofit group.

    By Rebecca Pifer Parduhn • Nov. 21, 2018
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    FDA details ramp-up of postmarket device oversight

    The agency laid out plans to increase postmarket surveillance of medical devices and previewed details coming next week on how it expects to modernize premarket reviews, especially the 510(k) process.

    By Nov. 21, 2018
  • Image attribution tooltip
    Intermountain Healthcare
    Image attribution tooltip

    Telehealth laws inhibit widespread use in Medicare population, CMS says

    The agency is taking steps to open up virtual care options in some alternative payment models, but use among fee-for-service beneficiaries is only 0.25%, according to a new report.

    By Meg Bryant • Nov. 19, 2018
  • Image attribution tooltip
    Deposit Photor
    Image attribution tooltip

    Abbott seeks clearer security standards as feds increase cyber risk focus

    President Trump is expected to sign legislation Friday creating a new cyber agency within the Department of Homeland Security. 

    By Maria Rachal • Nov. 16, 2018
  • CMS' Verma outlines vision for connected digital health network

    The agency also submitted a report to Congress on the state of Medicare telehealth, outlining how beneficiaries are currently using remote care and how CMS is looking to further expand similar services to rural areas.

    By Nov. 16, 2018
  • House chairman sees 'every indication' that VA's EHR difficulties will continue

    "Frankly," Indiana Rep. Jim Banks said, "the more I learn about the EHR program, the more daunting it has become." 

    By Tony Abraham • Nov. 15, 2018
  • AdvaMed makes lame duck push for medical device tax repeal

    Given the impending Democratic control of the House, the trade group's CEO Scott Whitaker said "the chances are not as great next year" for permanent repeal if the industry does not garner a victory.

    By David Lim • Nov. 15, 2018
  • Image attribution tooltip
    Credit: Andrew Propp, FDA / Edited by BioPharma Dive
    Image attribution tooltip

    FDA sounds alarm about off-label drug use in pain pumps

    The agency wants physicians to stick to approved drugs to reduce the risk of device failure in the pumps, which include those sold by Medtronic and J&J.

    By Nov. 15, 2018
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    US Vascular gets FDA warning letter for long-running problems

    Most of the points raised in the regulatory notice date back to a 2016 inspection.

    By Nov. 15, 2018
  • Image attribution tooltip
    Milken Institute
    Image attribution tooltip

    FDA plans to waive informed consent for some clinical trials

    The change would enable sponsors to run certain minimal-risk studies without gaining consent from participants. FDA said Friday it will reopen the comment period on the proposed rule.

    By Updated Feb. 22, 2019
  • Medtronic gets CE mark for low-profile thoracic endograft

    The clearance comes weeks after FDA approved the Valiant Navion TEVAR endograft.

    By Nov. 14, 2018
  • It's final: Amazon pegs NY, Virginia for HQ2 (with a nod to Nashville)

    Amazon will split its new North American headquarters over two sites. The city of Nashville is also a surprise winner, landing 5,000 jobs as part of an "operations center of excellence," the company said Tuesday.

    By Samantha Liss • Nov. 13, 2018
  • Grassley questions FDA about 'troubling' cybersecurity audit

    "Medical devices could be exploited by those same foreign actors to not only interfere with normal device operation, which could cause harm to patients, but also to steal personal medical information," the senator wrote.

    By Nov. 13, 2018
  • Image attribution tooltip
    FDA
    Image attribution tooltip
    Deep Dive

    3D printing poised to disrupt healthcare

    Health industry types are "100% convinced, and rightly so, that [3D printing] will be a core part of their business in five to 10 years," ISG's Michael Harmon said.

    By Meg Bryant • Nov. 12, 2018
  • FDA clears battery-powered Ebola test for emergency use

    The regulatory decision adds to the testing capabilities of public health clinics and treatment centers.

    By Nov. 12, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Monteris modifies brain ablation device to counter safety risk

    FDA cleared a new model that features a fiber optic probe designed to stop the original heating problem.

    By Nov. 9, 2018
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Better broadband needed to meet telehealth needs, USDA report warns

    People who use telehealth services tend to live in urban areas and have more education and higher incomes, according to the agency's report.

    By Meg Bryant • Nov. 8, 2018
  • Deep Dive

    Red states say 'yes' to Medicaid; DME gets boost in Nevada

    Three GOP-heavy states expanded Medicaid on Tuesday, and Democratic governor pickups in other parts of the country could further the trend. Elsewhere, durable medical equipment makers scored a win in Nevada.

    By Rebecca Pifer Parduhn • Nov. 7, 2018
  • Image attribution tooltip
    Getty
    Image attribution tooltip

    Abbott, J&J take part in FDA's NEST real world evidence pilot

    The test cases will assess the role of RWE in proactive post-market surveillance, the evaluation of ablation devices and other activities across the medical device lifecycle.

    By Nov. 6, 2018
  • Pact to rush medical products for military clinched

    The memorandum signed by the FDA and Department of Defense formalizes a program to speed review of high-priority treatments for the military such as freeze-dried plasma.

    By Nov. 5, 2018
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    ACLA praises CMS for boosting data collection

    The clinical lab trade group lauded the agency for taking steps to increase the number of laboratories submitting data informing Medicare payment rates.

    By David Lim • Nov. 5, 2018
  • Image attribution tooltip
    Parker Johnson on Unsplash
    Image attribution tooltip
    Deep Dive

    Midterms 2018: Key health ballot votes in the states

    It's not just Congress up for grabs in Tuesday's midterm elections. From Medicaid expansion to dialysis treatments to nurse staffing ratios, here's a snapshot of key votes, the odds and what they could mean for the industry.

    By David Lim , Tony Abraham , Rebecca Pifer Parduhn , Samantha Liss • Nov. 2, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    CMS finalizes DME bidding program overhaul despite cost

    Administrator Seema Verma said the final rule will increase patient access to medical products, but an August GAO report found beneficiaries are able to get needed items under the current paradigm.

    By David Lim • Nov. 2, 2018